Skip to content

Reverse Fly Exercise On Supraspinatus Tendinitis In Patients Receiving Aromatase Inhibitors Therapy After Mastectomy

Reverse Fly Exercise On Supraspinatus Tendinitis In Patients Receiving Aromatase Inhibitors Therapy After Mastectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07763080
Enrollment
40
Registered
2026-08-13
Start date
2026-08-18
Completion date
2027-07-11
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aromatase Inhibitors Therapy, Mastectomy

Keywords

Mastectomy, Aromatase inhibitors therapy

Brief summary

Reverse Fly Exercise On Supraspinatus Tendinitis In Patients Receiving Aromatase Inhibitors Therapy After Mastectomy

Detailed description

40 female patients who have mastectomy and receiving aromatase inhibitor therapy will participate in this study. Their ages will be ranged from 50 to 70 years. The participants will be selected from (national cancer institution Design of the study: In this study the patients will be randomly assigned into two equal groups Group A (Study group): This group will include 20 patients who will receive after 3:6 weeks from starting aromatase inhibitor the reverse fly exercise , in additions Traditional treatment for tendonitis post mastectomy and their medical treatment. (physiotherapeutic treatments 3 times a week for 8 weeks , including , (pendulum ex , soft tissue release , stretching ex., strengthening ex. and ROM ex.) and their medical treatment. Group B (Control group): This group includes 20 patients who will receive the traditional physical therapy program (pendulum ex , soft tissue release, stretching ex., strengthening ex. and ROM ex.) and their medical treatment ,3 times a week for 8 weeks.

Interventions

OTHERReverse fly excercise

The procedure Stand with feet shoulder width apart while holding a dumbbell in each hand Flex the hips and knees slightly leaning the trunk forward while maintaining a neutral spine Allow the arms to hang perpendicular to the floor with elbows slightly flexed Horizontally abduct the shoulders by lifting the arms laterally until they are level with the shoulders Retract the scapulae at the top of the movement without elevating the shoulders Lower the arms slowly and with control back to the starting position Repeat for the desired number of repetitions

OTHERControl group

This group includes 20 patients who will receive the traditional physical therapy program (pendulum ex , soft tissue release, stretching ex., strengthening ex. and ROM ex.) and their medical treatment ,3 times a week for 8 weeks. 1.2 Criteria for the patient selection:

Sponsors

Cairo University
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Intervention model description

RCT study

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age range between 50:70 years. * Female patients participate in the study. * All patients with unilateral mastectomy. * Patients who receiving aromatase inhibitors treatment. * All patients will enroll in this study with have their informed consent.

Exclusion criteria

* Patients have Metastases * Patients with Lymphedema * Patients with Rheumatoid arthritis * Patients have Neurological deficits (stroke, Parkinsonism) * Patients with Psychological disorders

Design outcomes

Primary

MeasureTime frameDescription
Supraspinatus Tendon ThicknessBefore 1st physical therapy session And after 8 weeks of regular 3 session per week of physical therapyUsing Dynamic ultrasonography for measuring
Functional abilityBefore 1st physical therapy session And after 8 weeks of regular 3 sessions/week of physical therapyBy Quik DASH Questionnaire

Countries

Egypt

Contacts

CONTACTNourhan Ahmed Mahmoud Souliman, Master degree
nourhan.souliman@pt.cu.edu.eg+201112852496

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026